Basic Information
| LncRNA/CircRNA Name | ENST00000425005 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | RT-PCR, Western blot |
| Sample | liver cancer cell lines |
| Expression Pattern | up-regulated |
| Function Description | lncRNA ENST00000425005 promotes cell proliferation and invasion in drug-resistant liver cancer cells by regulating epithelial-mesenchymal transition-related gene expression and participating in the regulation of EGF and FGF7. |
| Pubmed ID | 31704308 |
| Year | 2019 |
| Title | Mechanism of aberrant long non-coding RNA expression in an adriamycin-resistant liver cancer cell strain |
External Links
| Links for ENST00000425005 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |